Accelerate Diagnostics (AXDX)
(Real Time Quote from BATS)
$0.86 USD
+0.09 (11.69%)
Updated Apr 19, 2024 01:32 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Earnings News For AXDX
-
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
-
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Accelerate Diagnostics: Q3 Earnings Snapshot
-
Accelerate Diagnostics Reports Third Quarter 2023 Results
-
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.
-
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
-
Accelerate Diagnostics: Q2 Earnings Snapshot
-
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results
-
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results
-
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates
-
Accelerate Diagnostics: Q1 Earnings Snapshot
-
Accelerate Diagnostics Reports First Quarter 2023 Financial Results
-
Accelerate Diagnostics scheduled call to review 2023 first quarter results
-
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
-
Accelerate Diagnostics: Q4 Earnings Snapshot
-
Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Accelerate Diagnostics: Q3 Earnings Snapshot
-
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
-
Accelerate Diagnostics scheduled call to review 2022 third quarter results
-
Accelerate Diagnostics: Q2 Earnings Snapshot
-
Accelerate Diagnostics Reports Second Quarter 2022 Financial Results
-
Accelerate Diagnostics scheduled call to review 2022 second quarter results
-
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Tops Revenue Estimates
-
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Tops Revenue Estimates
-
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release